"Sulfasalazine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
| Descriptor ID |
D012460
|
| MeSH Number(s) |
D02.065.884.730 D02.886.590.700.730
|
| Concept/Terms |
Sulfasalazine- Sulfasalazine
- Sulphasalazine
- Salazosulfapyridine
- Salicylazosulfapyridine
|
Below are MeSH descriptors whose meaning is more general than "Sulfasalazine".
Below are MeSH descriptors whose meaning is more specific than "Sulfasalazine".
This graph shows the total number of publications written about "Sulfasalazine" by people in this website by year, and whether "Sulfasalazine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 2 | 3 | 5 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Sulfasalazine" by people in Profiles.
-
A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD. Sci Rep. 2021 08 13; 11(1):16522.
-
Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic. Adv Emerg Nurs J. 2021 Jul-Sep 01; 43(3):194-197.
-
Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies. Sci Adv. 2021 06; 7(27).
-
COVID-19 in IBD: The experience of a single tertiary IBD center. Dig Liver Dis. 2021 03; 53(3):271-276.
-
Revisiting the cardiovascular risk of hydroxychloroquine in RA. Nat Rev Rheumatol. 2020 12; 16(12):671-672.
-
Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance? Int J Dermatol. 2021 Jan; 60(1):125-126.
-
Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases. Clin Gastroenterol Hepatol. 2021 02; 19(2):394-396.e5.
-
[DRESS syndrome simulating coronavirus 2019-NcoV disease]. Semergen. 2021 Jan-Feb; 47(1):56-58.
-
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Gastroenterology. 2020 08; 159(2):481-491.e3.
-
Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial. Clin Rheumatol. 2019 Mar; 38(3):841-849.